On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
We have now added a new section called the "Assay History List" to the "At A Gla...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...